<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02107105</url>
  </required_header>
  <id_info>
    <org_study_id>2013-0631</org_study_id>
    <secondary_id>NCI-2020-07835</secondary_id>
    <secondary_id>2013-0631</secondary_id>
    <secondary_id>K07CA133187</secondary_id>
    <nct_id>NCT02107105</nct_id>
  </id_info>
  <brief_title>Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer</brief_title>
  <official_title>Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates quality of life and utilities following surgical treatment of stage I-IV&#xD;
      rectal cancer. This study may help researches learn more about quality of life in patients&#xD;
      who have or have had rectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To assess post-treatment related health state utilities among patients with rectal cancer&#xD;
      after treatment at 2 years.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To longitudinally compare the effects of treatment on quality of life and utilities among&#xD;
      patients treated with or without (neo)adjuvant radiation therapy.&#xD;
&#xD;
      II. To characterize the impact of treatment on quality of life and utilities among patients&#xD;
      with rectal cancer.&#xD;
&#xD;
      III. To assess changes in quality of life and utilities among patients treated for rectal&#xD;
      cancer over time.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12&#xD;
      months after surgery, and 2, 3, 4, and 5 years after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 16, 2014</start_date>
  <completion_date type="Anticipated">May 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health state utilities</measure>
    <time_frame>At 24 months post-surgery</time_frame>
    <description>A health state utility is the degree of preference that individuals or society has for a particular health state or condition.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Rectal Adenocarcinoma</condition>
  <condition>Stage I Rectal Cancer AJCC v8</condition>
  <condition>Stage II Rectal Cancer AJCC v8</condition>
  <condition>Stage IIA Rectal Cancer AJCC v8</condition>
  <condition>Stage IIB Rectal Cancer AJCC v8</condition>
  <condition>Stage IIC Rectal Cancer AJCC v8</condition>
  <condition>Stage III Rectal Cancer AJCC v8</condition>
  <condition>Stage IIIA Rectal Cancer AJCC v8</condition>
  <condition>Stage IIIB Rectal Cancer AJCC v8</condition>
  <condition>Stage IIIC Rectal Cancer AJCC v8</condition>
  <condition>Stage IV Rectal Cancer AJCC v8</condition>
  <condition>Stage IVA Rectal Cancer AJCC v8</condition>
  <condition>Stage IVB Rectal Cancer AJCC v8</condition>
  <condition>Stage IVC Rectal Cancer AJCC v8</condition>
  <arm_group>
    <arm_group_label>Observational (questionnaire)</arm_group_label>
    <description>Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12 months after surgery, and 2, 3, 4, and 5 years after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Complete quality of life questionnaire</description>
    <arm_group_label>Observational (questionnaire)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete quality of life questionnaire</description>
    <arm_group_label>Observational (questionnaire)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with stave I-IV rectal adenocarcinoma at the Colorectal Clinic at M D Anderson&#xD;
        Cancer Center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is&#xD;
             planned to be treated by surgical resection performed with curative intent, or who has&#xD;
             already received surgical treatment&#xD;
&#xD;
          -  Patient must sign an approved informed consent document and have the literary and&#xD;
             physical ability to complete the questionnaire in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient has been treated with pelvic radiation therapy for a diagnosis other than&#xD;
             rectal cancer&#xD;
&#xD;
          -  Patient has a concurrent cancer diagnosis at the time of consent&#xD;
&#xD;
          -  Patient has recurrent disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George J Chang</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>George Chang</last_name>
    <phone>713-792-6940</phone>
    <email>GChang@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George J. Chang</last_name>
      <phone>713-792-6940</phone>
    </contact>
    <investigator>
      <last_name>George J. Chang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>University of Texas MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 4, 2014</study_first_submitted>
  <study_first_submitted_qc>April 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2014</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

